Financials

	2017	2018
Net sales	2.02Cr 1.75Cr 1.64Cr 1.5Cr 2.82Cr 193.08Cr 2.87Cr 19Cr 7.54Cr 97Cr 7.6Cr 7.44Cr 321.72Cr	2.64Cr 2.29Cr 2.14Cr 1.95Cr 3.68Cr 251.77Cr 3.74Cr 25Cr 9.83Cr 125.95Cr 9.91Cr 9.7Cr 419.49Cr
Net income	-4.93Cr -4.27Cr -3.99Cr -3.65Cr -6.87Cr -470.2Cr -6.98Cr -47Cr -18Cr -235.23Cr -19Cr -18Cr -783.45Cr	-4.59Cr -3.98Cr -3.72Cr -3.4Cr -6.4Cr -438.04Cr -6.5Cr -44Cr -17Cr -219.14Cr -17Cr -17Cr -729.86Cr
Net Debt	1Cr 86.99L 81.31L 74.31L 1.4Cr 96Cr 1.42Cr 9.53Cr 3.74Cr 48Cr 3.77Cr 3.69Cr 159.67Cr	-73.03L -63.22L -59.09L -54.01L -1.02Cr -70Cr -1.03Cr -6.93Cr -2.72Cr -35Cr -2.74Cr -2.68Cr -116.05Cr

Company Profile

Valeritas Holdings Inc is a United States-based company. The Company provides surgical & medical instruments & apparatus.

Employees

Sector

Delayed OTC Markets Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-4.76%	-96.52%

30/20/30	Valeritas Holdings, Inc. Went Out of Business	CI
08/20/08	First Amended Combined Joint Liquidation Plan & Disclosure Statement Approved for Valeritas Holdings, Inc.	CI

30/20/30	Valeritas Holdings, Inc. Went Out of Business	CI
08/20/08	First Amended Combined Joint Liquidation Plan & Disclosure Statement Approved for Valeritas Holdings, Inc.	CI
03/20/03	First Motion for Exclusivity Period Extension Approved For Valeritas Holdings, Inc.	CI
21/20/21	First Motion for Exclusivity Period Extension Filed by Valeritas Holdings, Inc.	CI
21/20/21	Combined Disclosure Statement and Liquidation Plan Approved for Solicitation Purpose on Interim Basis for Valeritas Holdings, Inc.	CI
15/20/15	First Amended Combined Joint Liquidation Plan & Disclosure Statement Filed by Valeritas Holdings, Inc.	CI
06/20/06	Combined Joint Liquidation Plan & Disclosure Statement Filed by Valeritas Holdings, Inc.	CI
03/20/03	Valeritas Holdings, Inc. Announces Management Changes	CI
02/20/02	Zealand Pharma A/S completed the acquisition of substantially all assets of Valeritas Holdings, Inc.	CI
20/20/20	Motion for Asset Sale Approved for Valeritas Holdings, Inc.	CI
13/20/13	Final DIP Financing Approved for Valeritas Holdings, Inc.	CI
13/20/13	Notice for Auction Cancellation Filed by Valeritas Holdings, Inc.	CI
06/20/06	Bidding Procedure Approved for Valeritas Holdings, Inc.	CI

03/20/03	VALERITAS HOLDINGS INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	AQ
23/20/23	Valeritas : Receives Court Approval of Sale of Business to Zealand Pharma	PU
21/20/21	VALERITAS HOLDINGS INC. : Bankruptcy or Receivership, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
20/20/20	Valeritas : Receives Court Approval of Sale of Business to Zealand Pharma	PR
19/20/19	VALERITAS HOLDINGS INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	AQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VALERITAS HOLDINGS, INC.	-.--%	-4.76%	-	-	2L
ABBOTT LABORATORIES	+0.75%	+1.40%	-19.11%	+3.70%	19TCr
MEDTRONIC PLC	+2.58%	+3.15%	-3.74%	+7.57%	11TCr
CENCORA, INC.	+1.42%	+5.39%	+13.98%	+73.77%	6.2TCr
HOYA CORPORATION	+2.38%	+3.92%	+35.52%	+60.21%	5.53TCr
BECTON, DICKINSON AND COMPANY	+1.57%	+5.53%	-7.17%	-35.21%	4.89TCr
DEXCOM, INC.	+3.42%	+0.39%	+11.15%	-22.62%	3.31TCr
MEDLINE INC.	-4.03%	-16.46%	-	-	2.97TCr
WEST PHARMACEUTICAL SERVICES, INC.	-0.55%	+1.20%	+46.12%	-12.02%	2.48TCr
STERIS PLC	+0.61%	+2.70%	-1.62%	+5.14%	2.33TCr
Average	+0.82%	-0.03%	+9.39%	+10.07%	5.79TCr
Weighted average by Cap.	+1.25%	+2.14%	-0.12%	+12.40%